简约算法分类急性呼吸窘迫综合征表型的开发与验证
本研究基于五项随机对照试验数据,利用机器学习筛选出6个重要分类变量,并构建了三变量和四变量逻辑回归模型。外部验证显示模型识别的表型具有一致预后差异。
要点
- 高炎症表型患者90天死亡率更高(39% vs 23%),无呼吸机天数更少。
- 模型在外部试验中重现表型相关生存差异,如HARP-2中辛伐他汀疗效差异。
核心结论
- 使用三或四个变量的简约分类模型可准确识别ARDS的高炎症和低炎症表型。
研究设计与样本
- 回顾性研究,推导集来自三项RCT(ARMA、ALVEOLI、FACTT,n=2022),验证集为SAILS(n=715),外部验证用START和HARP-2数据集。
主要发现
- 六个最重要分类变量为IL-8、IL-6、蛋白C、可溶性TNF受体1、碳酸氢盐和血管加压药使用。
关键数值与推荐
- 三变量模型纳入IL-8、碳酸氢盐和蛋白C;四变量模型增加血管加压药使用。
临床怎么用
- 在实时生物标志物检测和前瞻性验证前,这些模型可促进ARDS表型识别,用于临床试验和实践。
局限性
- 研究为回顾性二次分析,仅使用完整生物标志物数据的病例进行变量选择。
- 需开发实时检测方法并进行前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Using latent class analysis (LCA) in five randomised controlled trial (RCT) cohorts, two distinct phenotypes of acute respiratory distress syndrome (ARDS) have been identified: hypoinflammatory and hyperinflammatory. The phenotypes are associated with differential outcomes and treatment response. The objective of this study was to develop parsimonious models for phenotype identification that could be accurate and feasible to use in the clinical setting. METHODS: In this retrospective study, three RCT cohorts from the National Lung, Heart, and Blood Institute ARDS Network (ARMA, ALVEOLI, and FACTT) were used as the derivation dataset (n=2022), from which the machine learning and logistic regression classifer models were derived, and a fourth (SAILS; n=715) from the same network was used as the validation test set. LCA-derived phenotypes in all of these cohorts served as the reference standard. Machine-learning algorithms (random forest, bootstrapped aggregating, and least absolute shrinkage and selection operator) were used to select a maximum of six important classifier variables, which were then used to develop nested logistic regression models. Only cases with complete biomarker data in the derivation dataset were used for variable selection. The best logistic regression models based on parsimony and predictive accuracy were then evaluated in the validation test set. Finally, the models' prognostic validity was tested in two external ARDS clinical trial datasets (START and HARP-2) by assessing mortality at days 28, 60, and 90 and ventilator-free days to day 28. FINDINGS: The six most important classifier variables were interleukin (IL)-8, IL-6, protein C, soluble tumour necrosis factor receptor 1, bicarbonate, and vasopressor use. From the nested models, three-variable (IL-8, bicarbonate, and protein C) and four-variable (3-variable plus vasopressor use) models were adjudicated to be the best performing. In the validation test set, both models showed good accuracy (AUC 0·94 [95% CI 0·92-0·95] for the three-variable model and 0·95 [95% CI 0·93-0·96] for the four-variable model) against LCA classifications. As with LCA-derived phenotypes, the hyperinflammatory phenotype as identified by the classifier model was associated with higher mortality at day 90 (87 [39%] of 223 patients vs 112 [23%] of 492 patients; p<0·0001) and fewer ventilator-free days (median 14 days [IQR 0-22] vs 22 days [0-25]; p<0·0001). In the external validation datasets, three-variable models developed in the derivation dataset identified two phenotypes with distinct clinical features and outcomes consistent with previous findings, including differential survival with simvastatin versus placebo in HARP-2 (p=0·023 for survival at 28 days). INTERPRETATION: ARDS phenotypes can be accurately identified with parsimonious classifier models using three or four variables. Pending the development of real-time testing for key biomarkers and prospective validation, these models could facilitate identification of ARDS phenotypes to enable their application in clinical trials and practice. FUNDING: National Institutes of Health.
引用
- Sinha P, Delucchi KL, McAuley DF, et al. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials. Lancet Respir Med. 2020. PMID: 31948926. doi:10.1016/S2213-2600(19)30369-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。